Medpace Holdings (MEDP) FCF Margin (2015 - 2026)
Medpace Holdings' (MEDP) quarterly FCF Margin came in at 19.52% in Q2 2026, down 408.0% YoY from 6.34% in Q2 2025, and down 4.84% on a QoQ basis from 20.52% in Q1 2026.
Medpace Holdings (MEDP) FCF Margin (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has 12 years of FCF Margin data on file, last reported at 19.52% in Q2 2026.
- Quarterly FCF Margin fell 408.0% year-over-year to 19.52% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 25.4% (down 58.0% YoY) and the FY2025 annual result came in at 26.95%, down 19.0% from the prior year.
- FCF Margin eased to 19.52% in Q2 2026, from 20.52% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 35.69% in Q3 2025 to a low of 11.18% in Q1 2022.
- A 5-year average of 24.03% and a median of 23.96% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin plunged 837 bps — and 2024, when it jumped 1254 bps.
- Tracing MEDP's FCF Margin over 5 years: stood at 32.34% in 2022, then slipped by 9 bps to 29.38% in 2023, then increased by 16 bps to 34.11% in 2024, then decreased by 22 bps to 26.55% in 2025, then slipped by 26 bps to 19.52% in 2026.
- The last three FCF Margin figures came in at 19.52% (Q2 2026), 20.52% (Q1 2026), and 26.55% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 13.97% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 20.19% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 26.51% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 10.95% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.24% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 2.59% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 13.89% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 27.51% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn | 19.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.52% |
| Mar 31, 2026 | 20.52% |
| Dec 31, 2025 | 26.55% |
| Sep 30, 2025 | 35.69% |
| Jun 30, 2025 | 23.61% |
| Mar 31, 2025 | 20.74% |
| Dec 31, 2024 | 34.11% |
| Sep 30, 2024 | 25.98% |
| Jun 30, 2024 | 19.60% |
| Mar 31, 2024 | 28.80% |
| Dec 31, 2023 | 29.38% |
| Sep 30, 2023 | 21.46% |
| Jun 30, 2023 | 16.07% |
| Mar 31, 2023 | 16.26% |
| Dec 31, 2022 | 32.34% |
| Sep 30, 2022 | 26.40% |
| Jun 30, 2022 | 24.32% |
| Mar 31, 2022 | 11.18% |
| Dec 31, 2021 | 20.02% |
| Sep 30, 2021 | 22.23% |